Yale Nobel Laureate Honored with Connecticut Medal of Science
News Apr 22, 2013
Best known for his research into ribosomal proteins, the building blocks of all life, Steitz is also renowned for his work with dozens of student mentees who became scientific leaders, themselves.
Steitz co-founded New Haven-based Rib-X Pharmaceuticals in 2001 to develop new classes of antibiotics. Today, the company has 45 full-time employees.
In addition to the 2009 Nobel Prize in Chemistry, Steitz has received a Gairdner International Award, a Keio Medical Science Prize, the AAAS Newcomb Cleveland Prize, and many other honors.
Protein's Role in Mitochondrial Metabolism IdentifiedNews
EXD2, a protein previously thought to be localised to the nucleus, has a key role in the production of proteins by mitochondria.READ MORE
Being Born During a Flu Pandemic May Increase Your Risk of Death During Another Flu PandemicNews
While past exposure to influenza A viruses often builds immunity to similar, and sometimes different, strains of the virus, researchers are calling for more attention to exceptions to that rule.READ MORE
Glythera Appoints Chief Scientific Officer and Strengthens SABNews
Dr Robert Lutz appointed as CSO to support development of next-generation PermaLink® Antibody Drug Conjugates. Dr Jon Roffey appointed to Scientific Advisory Board.READ MORE